(C) Positive correlation betweenERBB3gene expression in normal breast specimens and a molecular score of the degree of luminal differentiation (20). epithelium (BE) occurred upon ErbB3 targeting in the luminal epithelium, but not upon its targeting in the BE. Multiple cytokines, including interleukin 6, were induced upon ErbB3 depletion in luminal epithelium cells, which increased growth of BE cells. Taken together, these results suggest that ErbB3 regulates the balance of differentiated breast epithelial cell types by regulating their growth and survival through autocrine- and paracrine-signaling mechanisms. Keywords:mammary epithelial differentiation, ErbB3 Aberrant regulation of the ErbB family of receptor tyrosine kinases (RTKs) and their ligands is usually common in human cancers (14). CETP-IN-3 This family consists of four members: HER1/ErbB1/EGFR (epidermal growth factor receptor), HER2/ErbB2/Neu, HER3/ErbB3, and HER4/ErbB4. Except for ErbB3, which has poor kinase activity, the ErbB RTKs exhibit dimerization-induced phosphorylation and catalytic activation. In response to ligand binding, ErbBs form homodimers and heterodimers with other ErbB coreceptors. ErbB3 relies on transphosphorylation by heterodimeric partners to induce signal transduction (57). ErbB RTKs are required for breast development, although each receptor bears a unique spatiotemporal expression pattern.ErbB2loss in the mammary epithelium delays ductal elongation during puberty and disorganizes cells within terminal end buds (TEBs) (810).EGFRandErbB4are not required for mammary ductal development. Rather, EGFR is usually expressed in the basal epithelium (BE) and in the mammary stroma, and ErbB4 is necessary for milk production (11,12). Although classical knockout of mouseErbB3results in embryonic lethality (13), transplant experiments showed that ErbB3 drives growth of the mammary epithelium during puberty (8). Although the mechanism(s) by which ErbB2 and ErbB3 regulate growth of the ductal epithelium are currently unknown, such knowledge will impact our understanding of the earliest events contributing to the formation of ErbB2/HER2-amplified breast cancers, which account for 2030% of all breast cancers. ErbB3-ErbB2 heterodimers are the most potent oncogenic ErbB-signaling pair due in part to strong ErbB3-induced phosphatidylinositol 3-kinase (PI3K) activation in response to ErbB3 tyrosine phosphorylation at six PI3K conversation motifs (14,15). To understand the role of ErbB3 in mammary gland development, we knocked outERBB3in mammary epithelial cells (MECs) and tumors using a mouse mammary tumor computer virus (MMTV)-driven Cre/lox system (ErbB3MMTV-KO) (16), which expresses Cre recombinase primarily in the mammary luminal epithelium (LE). We discovered that ErbB3 is required in the LE, but not in the BE, to support cell proliferation and survival. Loss of ErbB3 decreased MEK/MAPK and PI3K/Akt signaling and impaired differentiation of MECs along the luminal lineage. Definitive LE markers were decreased in the absence of ErbB3, and rescued upon reactivation of Akt and MEK. In contrast, the BE exhibited increased cell proliferation when ErbB3 was lost from the LE, suggesting communication between these two epithelial compartments. ErbB3-depleted LE cells produced mitogenic cytokines, which increased BE growth. These data demonstrate Rabbit polyclonal to HERC4 that ErbB3 maintains the LE at the luminal progenitor stage and regulates the balance of differentiated epithelial cell types within the CETP-IN-3 mammary gland through both autocrine and paracrine mechanisms. == Results == == ErbB3 Directs Growth, Survival, and Business of the Developing Mammary Epithelium. == The mammary ductal epithelium begins lengthening distally through the mammary excess fat pad during puberty. Proliferation of the mammary epithelium and invasion through the excess fat pad occur primarily within club-shaped multicell-layered TEBs located at the distal-most aspects of the growing ducts. TEBs consist of two main cell layers: the cap layer, which gives rise to the BE, and the body layer, which gives rise to the LE. ErbB3 protein expression was higher in TEB body cells than in cap CETP-IN-3 cells (Fig. 1A). ErbB3 was substantially reduced in TEBs of ErbB3MMTV-KOmice, which use MMTV-Cre transgene expression in the LE to cause genomic recombination at floxed ErbB3 alleles in ErbB3FL/FLmice (16). Ductal lengthening during puberty was delayed in 8-wk-old ErbB3MMTV-KOvirgin female mice compared with heterozygous ErbB3FL/+ MMTV-Cre controls (Fig. 1A), although ducts permeated the full length of the mammary excess fat pads by 16 wk of age in ErbB3MMTV-KOfemale mice (Fig. S1);ErbB3flox/+heterozygotes showed no change in mammary phenotype compared with wild-type (WT) mice (16) and CETP-IN-3 were used as controls. Decreased thickness of the TEB body cell layer was evident in ErbB3MMTV-KOsamples (Fig. 1B) due in part to decreased cellular proliferation as measured by Ki67 immunohistochemistry (IHC). In heterozygous TEBs, E-cadherin IHC-defined body cells organized in a multilayered club-shaped pattern. TEBs in ErbB3MMTV-KOmice displayed thinning E-cadherin+body cell layers with undulating patterns of disorganization. Although easy muscle actin (SMA) identified a single layer of cap cells in heterozygous controls, ErbB3MMTV-KOTEBs harbored multiple layers of SMA+cap cells..